Stanford Residents Get 21% Raise in First Union Contract
Newly unionized resident physicians and fellows at Stanford Health Care in California will see a 21% pay increase over 3 ...
Newly unionized resident physicians and fellows at Stanford Health Care in California will see a 21% pay increase over 3 ...
Share on PinterestPoison control centers are seeing an uptick in calls related to Ozempic and Wegovy. myskin/ShutterstockPoison control centers are ...
The US Food and Drug Administration (FDA) today announced it has expanded the approval of tralokinumab-ldrm (Adbry) for treating moderate ...
For much of his life, 32-year-old Michael Smith had a war going on in his head.After a big meal, he ...
Share on PinterestMany pregnant people develop nausea or vomiting during pregnancy. Eclipse Images/Getty ImagesA new study has found evidence for ...
New research provides some reassuring news for young women hoping to become pregnant after a diagnosis of BRCA-mutated breast cancer.As ...
While glucagon-like peptide-1 (GLP-1) agonists for diabetes and weight loss remain in short supply, some clinicians have turned to compounding pharmacies to ...
Patients with locally advanced or metastatic bladder cancer have a permanent new first-line standard of care after the FDA granted ...
The US Food and Drug Administration (FDA) has approved an intracameral implant with 75 mcg of travoprost to reduce intraocular ...
One patient was wrongly identified as not to be resuscitated because of slow access to digital records. Source link : ...
Bass-heavy rock music applied directly to the abdomen of diabetic mice implanted with music-sensitive insulin-releasing cells attenuates postprandial glycemic excursions ...
Emily Hutto is an Associate Video Producer & Editor for MedPage Today. She is based in Manhattan. Jeremy Faust is ...
Treatment with a novel, oral JAK1 tyrosine kinase inhibitor induced rapid and durable responses in patients with relapsed or refractory ...
In patients hospitalized for either COVID-19 or seasonal influenza, rates of death, negative effects on long-term health, and hospital readmissions ...
TOPLINE:Shift workers are more prone to short sleep and a range of sleep disorders, a large Belgian study finds. The ...
Patients living in more disadvantaged neighborhoods were more likely to leave their prescriptions for standard heart failure medications unfilled, retrospective ...
A MedPage Today Clinical Challenges series on neurofibromatosis covered current management strategies, new treatment options on the horizon, and neurocognitive ...
SAN DIEGO -- A novel therapy for polycythemia vera (PCV) maintained stable hematocrit levels for as long as 2.5 years ...
Adding atezolizumab (Tecentriq) to carboplatin improved progression-free survival (PFS) and overall survival (OS) in patients with metastatic triple-negative breast cancer ...
The US Food and Drug Administration (FDA) has approved belzutifan (Welireg) for adults with advanced renal cell carcinoma following progression ...
© 2022 NewsHealth.
© 2022 NewsHealth.
Belzutifan Approved for Advanced Renal Cell Carcinoma- Belzutifan Approved for Advanced Renal Cell Carcinoma * Belzutifan Approved for Advanced Renal Cell Carcinoma | Belzutifan Approved for Advanced Renal Cell Carcinoma | Belzutifan Approved for Advanced Renal Cell Carcinoma | Belzutifan Approved for Advanced Renal Cell Carcinoma | Belzutifan Approved for Advanced Renal Cell Carcinoma | Belzutifan Approved for Advanced Renal Cell Carcinoma | Belzutifan Approved for Advanced Renal Cell Carcinoma | Belzutifan Approved for Advanced Renal Cell Carcinoma | | Belzutifan Approved for Advanced Renal Cell Carcinoma | | Belzutifan Approved for Advanced Renal Cell Carcinoma | | Belzutifan Approved for Advanced Renal Cell Carcinoma |
NEWSHEALTH : Belzutifan Approved for Advanced Renal Cell Carcinoma